The UAMS Myeloma Center is the most comprehensive center in the world for research and clinical care related to multiple myeloma and related diseases, such as Castleman Disease and Waldenstrom Macroglobulinemia. Our team of leading scientists and clinicians has pioneered many advances that have become standards of care, leading to improved survival rates. The Myeloma Center is known for its “bench to bedside” approach, continually translating advances in the laboratory into breakthrough clinical treatments.
We are committed to
- Accelerating curative therapies for multiple myeloma and related diseases through an integrated program of innovative research and high-quality, comprehensive patient care
- Customizing care based on each patient’s genetic profile and risk factors for truly personalized treatment
- Pushing the envelope of understanding and discovery to unravel the biology of multiple myeloma and maximize cure
Meet the UAMS Myeloma Center has been cancelled.
Latest News
UAMS Scientists Awarded Grants for Cancer ResearchMarch 17, 2020
Newly awarded grants are advancing research efforts at the UAMS Winthrop P. Rockefeller Cancer Institute. Three Seeds of Science small grant awards of $50,000 each were presented March 5 to UAMS cancer researchers at “The Doctor is in” event hosted by the Envoys volunteer advocacy group.
Arkansan’s Golf Swing Breaks Back, Leads to Myeloma DiagnosisMarch 3, 2020
In 2017, Wade Bennett of Hackett, Arkansas, was 50, and physically active, both in his work as the owner of his company, WB Drywall, and in his leisure time.
Fenghuang (Frank) Zhan, M.D., Ph.D., Joins UAMS Myeloma CenterFebruary 5, 2020
Myeloma expert Fenghuang “Frank” Zhan, M.D., Ph.D., has joined the University of Arkansas for Medical Sciences (UAMS) as research director of the Myeloma Center.
Grateful Cancer Patient Pedals to Promote Myeloma CenterJanuary 16, 2020
David Sutton of St. Petersburg, Florida, was 42 and had an 18-month-old son when, on New Year’s Eve of 2004, he was diagnosed with myeloma and given a bleak prognosis from a cancer treatment center near his home.